Femme et Homme
- | Pays :
- Germany
- | Organes : -
- | Spécialités : -
Extrait
This study is designed to demonstrate that formoterol 12µg and 24µg delivered by a new inhalation device (Concept1) are equivalent to the corresponding dose of formoterol delivered by the Aerolizer device in terms of efficacy, in patients with persistent asthma.
Critère d'inclusion
- Asthma